Expert Reviews and Commentary

Treating MRSA Skin and Soft Tissue Infections -- New Guidelines Dr. Bartlett offers a practical step-by-step guide for MRSA treatment according to the most recent IDSA recommendations.
Experts And Viewpoints, April 29, 2011
Top 10 Infectious Diseases Hot Topics: 2010-2011 Dr. John Bartlett summarizes where we stand and what the future holds in the fast-moving world of infectious disease.
January 05, 2011
HIV and ID Articles of the Month John Bartlett reviews and comments on the top infectious disease and HIV articles of the month.
Experts And Viewpoints, December 03, 2010
HIV and ID Articles of the Month John Bartlett selects and reviews his picks for the top infectious disease articles of the month.
Experts And Viewpoints, September 30, 2010
Heterosexual HIV Transmission, Risk for MI From HAART John Bartlett selects and reviews the top infectious disease and HIV articles published this month.
Experts And Viewpoints, August 06, 2010
Postoperative Infections, HIV Deaths, and Copy-Years Viremia John Bartlett selects and reviews the top infectious disease and HIV articles.
Experts And Viewpoints, July 30, 2010
ID and HIV Articles of the Month John Bartlett selects and reviews the top infectious disease articles each month.
Experts And Viewpoints, June 17, 2010
Smoking and Mortality in HIV Infection Current smokers with HIV infection have 4 times higher risk for death than those without HIV infection.
Experts And Viewpoints, June 10, 2010
Universal Voluntary Testing and Treatment for Prevention of HIV Transmission Can a voluntary, universal test-and-treat strategy curb the global AIDS epidemic?
Experts And Viewpoints, May 13, 2010
Markers of Microbial Translocation and Immune Function in HIV Infection A recent study provides more evidence for the key role of the gut and gut bacteria in the pathogenesis of HIV disease.
Experts And Viewpoints, April 30, 2010
Discordance Between Viral Load Suppression and CD4 Cell Recovery: How Often and Why? John G. Bartlett, MD, discusses a study that reviews some of the reasons why your HIV patient's CD4 count may not recover despite viral load suppression.
Experts And Viewpoints, November 24, 2009
Plasma HIV RNA is a Risk Factor for Non-Hodgkin's Lymphoma John G. Bartlett, MD, comments on this observational study that establishes viral load as a risk factor for non-Hodgkin's lymphoma in people living with HIV/AIDS.
Experts And Viewpoints, November 17, 2009
Evidence for Why TB Strikes Early in HIV Disease Tuberculosis precedes other opportunistic infections in persons with HIV infection; this preclinical study suggests a biologic mechanism for that susceptibility. Commentary by John G. Bartlett, MD.
Experts And Viewpoints, August 17, 2009
Does Valganciclovir Reduce Oral HHV-8? This study set out to prove anecdotal evidence that valganciclovir reduces oral shedding of HHV-8. Are more trials needed?
Experts And Viewpoints, June 16, 2009
Maraviroc in Patients With "3-Class Failure" A new CC chemokine receptor 5 antagonist joins the HIV armamentarium, but how well does it perform in patients with multiple previous failed antiretroviral regimens?
Experts And Viewpoints, June 09, 2009
HIV-Associated Kidney Disease What increases the risk for chronic kidney disease in patients with HIV? Do antiretroviral agents add to this risk?
Experts And Viewpoints, June 02, 2009
HIV-Associated Rheumatic Conditions This extensive literature review synthesizes hundreds of reports of rheumatic conditions seen in patients with HIV.
Experts And Viewpoints, June 01, 2009
Comorbidities Unrelated to HIV/AIDS in HIV-Infected Patients Can treatment with HAART lower the incidence of complications that are unrelated to HIV infection?
March 24, 2009
Universal Voluntary HIV Testing With Immediate ART Can immediate treatment of every HIV-infected person stall the epidemic? A mathematical model indicates that it can, but study in the real world is crucial.
March 26, 2009
Raltegravir for Triple-Resistant HIV Raltegravir is a new HIV-1 integrase inhibitor. These 2 studies looked at its efficacy in patients with triple-drug resistance and at subgroup and resistance analyses.
Experts And Viewpoints, March 06, 2009

No Results